Syndax Pharmaceuticals (SNDX) Raw Materials (2025 - 2026)
Syndax Pharmaceuticals (SNDX) recorded quarterly Raw Materials of $30.7 million in Q1 2026, up 5.75% quarter-over-quarter from $29.0 million in Q4 2025, and up 1661.04% on a YoY basis from $1.7 million in Q1 2025.
Syndax Pharmaceuticals (SNDX) Raw Materials (2025 - 2026) Analysis & Trends
Syndax Pharmaceuticals' Raw Materials history runs 2 years deep, the most recent figure standing at $30.7 million for Q1 2026.
- In Q1 2026, Raw Materials rose 1661.04% year-over-year to $30.7 million; the TTM figure through Mar 2026 stood at $30.7 million (up 1661.04% YoY), while the FY2025 annual figure was $29.0 million, changed N/A from the prior year.
- Raw Materials was $30.7 million for Q1 2026 at Syndax Pharmaceuticals, up from $29.0 million in the prior quarter.
- In the past five years, Raw Materials ranged from a high of $30.7 million in Q1 2026 to a low of $1.7 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Syndax Pharmaceuticals | 1.69 Bn | 1.34 Bn | 53.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.70 Mn |
| Dec 31, 2025 | 29.03 Mn |
| Sep 30, 2025 | 21.40 Mn |
| Jun 30, 2025 | 14.18 Mn |
| Mar 31, 2025 | 1.74 Mn |